Standout Papers
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study (2017)
- Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (2017)
Immediate Impact
4 by Nobel laureates 6 from Science/Nature 65 standout
Citing Papers
Natural killer cell therapies
2024 StandoutNature
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Caroline Even being referenced
TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
2018
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Caroline Even | 1706 | 817 | 659 | 795 | 141 | 2.4k | |
| G Schwaab | 1413 | 996 | 1108 | 690 | 92 | 2.9k | |
| Dan P. Zandberg | 1289 | 618 | 428 | 409 | 95 | 2.1k | |
| Nicole G. Chau | 1224 | 468 | 758 | 439 | 79 | 2.2k | |
| Glenn J. Hanna | 1313 | 693 | 489 | 547 | 143 | 2.5k | |
| Yungan Tao | 1002 | 1022 | 719 | 631 | 109 | 2.2k | |
| Hyunseok Kang | 1916 | 992 | 970 | 862 | 101 | 3.2k | |
| Ammar Sukari | 1458 | 361 | 301 | 615 | 114 | 2.2k | |
| Yan‐Qun Xiang | 889 | 834 | 524 | 408 | 94 | 1.9k | |
| Joonas H. Kauppila | 790 | 427 | 1248 | 880 | 120 | 2.6k | |
| Antonio López–Pousa | 1748 | 792 | 847 | 1908 | 181 | 3.5k |
All Works
Loading papers...